retatrutide tachycardia semaglutide From single to triple agonists — the new era of pharmacological weight loss. Semaglutide ➝ Tirzepatide ➝ Satiety. Insulin sensitivity. Energy expenditure. Science is finally attacking obesity from multiple hormonal Retatrutide - Research Dosing &

Description

A recent study from the University of Copenhagen raises new concerns about GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, highlighting potential bone density loss

GLP-1 Causes of Overweight or Obesity Modern lifestyles, characterized by the rush and time constraints, have significantly changed eating habits

On December 23, 2024, the FDA approved the first generic Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor agonist

While nausea typically peaks during weeks 6-8 and then improves substantially, constipation can appear at any point and may persist throughout treatment